BAMF
WST icon

BI Asset Management Fondsmaeglerselskab’s West Pharmaceutical WST Stock Holding History

BI Asset Management Fondsmaeglerselskab’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.73M Buy
7,614
+6,022
+378% +$1.84M 0.02% 362
2026
Q1 		$399K Sell
1,592
-3,623
-69% -$901K ﹤0.01% 567
2025
Q4 		$1.44M Buy
5,215
+336
+7% +$91.9K 0.01% 465
2025
Q3 		$1.28M Buy
4,879
+620
+15% +$151K 0.01% 473
2025
Q2 		$932K Buy
4,259
+2,240
+111% +$479K 0.01% 499
2025
Q1 		$452K Sell
2,019
-1,013
-33% -$279K 0.01% 580
2024
Q4 		$993K Sell
3,032
-1,131
-27% -$356K 0.01% 515
2024
Q3 		$1.25M Buy
4,163
+777
+23% +$238K 0.02% 353
2024
Q2 		$1.11M Buy
3,386
+77
+2% +$27.2K 0.02% 377
2024
Q1 		$1.31M Buy
3,309
+1,348
+69% +$499K 0.02% 316
2023
Q4 		$691K Sell
1,961
-241
-11% -$85.3K 0.01% 465
2023
Q3 		$826K Buy
2,202
+148
+7% +$57.2K 0.02% 406
2023
Q2 		$786K Buy
2,054
+67
+3% +$23.9K 0.02% 398
2023
Q1 		$688K Buy
1,987
+651
+49% +$190K 0.02% 400
2022
Q4 		$314K Buy
+1,336
New +$317K 0.01% 474
2022
Q3 		– Sell
-530
Closed -$160K – 494
2022
Q2 		$160K Buy
+530
New +$172K 0.01% 429
2020
Q4 		– Sell
-3,972
Closed -$1.09M – 497
2020
Q3 		$1.09M Buy
3,972
+1,794
+82% +$475K 0.05% 271
2020
Q2 		$495K Buy
+2,178
New +$428K 0.03% 348
2020
Q1 		– Sell
-11,649
Closed -$1.75M – 391
2019
Q4 		$1.75M Sell
11,649
-7,905
-40% -$1.15M 0.08% 208
2019
Q3 		$2.77M Buy
+19,554
New +$2.69M 0.14% 136

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $6.78B AUM 31.6% 1-Year Est. Return
LGF
LGT Group Foundation Vaduz, Liechtenstein $8.84B AUM 31.56% 1-Year Est. Return

BI Asset Management Fondsmaeglerselskab's WST Position: Q2 2026 in Review

BI Asset Management Fondsmaeglerselskab increased its West Pharmaceutical (WST) stake by 378% in Q2 2026, buying an estimated $1.84M and bringing the position to 7,614 shares worth $2.73M. The position accounts for 0.02% of the portfolio, ranked #362.

BI Asset Management Fondsmaeglerselskab first reported a position in WST in Q3 2019 and has held it in 20 quarters since. The position peaked at $2.77M in Q3 2019. 433 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • BI Asset Management Fondsmaeglerselskab held 7,614 shares of West Pharmaceutical worth $2.73M as of Q2 2026.
  • BI Asset Management Fondsmaeglerselskab bought 6,022 West Pharmaceutical shares in Q2 2026, an estimated $1.84M.
  • West Pharmaceutical made up 0.02% of BI Asset Management Fondsmaeglerselskab's portfolio in Q2 2026, its #362 holding.
  • BI Asset Management Fondsmaeglerselskab first reported a position in West Pharmaceutical in Q3 2019 and has held it in 20 quarters since.
  • BI Asset Management Fondsmaeglerselskab's West Pharmaceutical position peaked at $2.77M in Q3 2019.
  • 433 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on BI Asset Management Fondsmaeglerselskab's 13F filing for Q2 2026, filed 10 Aug 2026.